MoneyWorks4Me

Coral Laboratories informs about receipt of notice

27 Apr 2026 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with applicable SEBI Circulars, Coral Laboratories has informed that the Company has received a notice under Section 18 of the Micro, Small and Medium Enterprises Development Act, 2006. It has enclosed the disclosure containing details as required under Regulation 30 read with Annexure A of the SEBI Circular.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1850.00
Dr. Reddys Labs. 1199.30
Cipla 1399.10
Lupin 2093.15
Zydus Lifesciences 1187.40
View more..